Globus Pallidus Externus In Movement Regulation is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The Globus Pallidus Externus (GPe) is a critical component of the basal ganglia, serving as a central hub in the indirect pathway that regulates movement. This GABAergic nucleus plays a fundamental role in motor control, and its dysfunction is implicated in several movement disorders including Parkinson's disease and Huntington's disease.
| Property |
Value |
| Category |
Basal Ganglia |
| Location |
Lentiform nucleus, lateral to the internal segment (GPi) |
| Cell Type |
GABAergic projection neurons |
| Neurotransmitter |
Gamma-aminobutyric acid (GABA) |
| Function |
Movement inhibition, motor timing |
¶ Anatomy and Physiology
The GPe is primarily composed of GABAergic projection neurons that express parvalbumin and produce dense axonal projections. These neurons have distinctive physiological properties:
- Fast-spiking activity: GPe neurons exhibit high-frequency firing patterns
- Input from striatum: Receive inhibitory projections from the striatum (via the indirect pathway)
- Output to STN: Provide inhibitory feedback to the subthalamic nucleus
- Collaterals: Extensive recurrent collateral connections within the GPe
The GPe occupies a pivotal position in the basal ganglia circuit:
Striatum (indirect) → GPe → Subthalamic Nucleus → GPi/SNr → Thalamus → Cortex
- Inputs: Receives inhibitory input from the striatum (D2 receptor-expressing medium spiny neurons)
- Outputs: Projects to the subthalamic nucleus (STN), striatum, and pedunculopontine nucleus
- Modulation: Subject to dopaminergic modulation from the substantia nigra pars compacta (SNc)
The indirect pathway, comprising the striatum → GPe → STN → GPi/SNr → thalamus circuit, acts as a "brake" on movement. The GPe serves as the first relay station in this pathway:
- When the striatum is activated by cortical inputs, it inhibits GPe activity
- Reduced GPe activity disinhibits the STN
- STN hyperactivity increases GPi/SNr output, which suppresses thalamic drive to the cortex
- This results in movement inhibition
In Parkinson's disease, the loss of dopaminergic neurons in the substantia nigra pars compacta (SNc) leads to profound changes in GPe activity:
- Increased firing rate: GPe neurons show elevated baseline firing in PD
- Altered patterns: Emergence of burst firing and oscillatory activity
- Connectivity changes: Abnormal interactions with the STN and striatum
The classic model of Parkinson's disease suggests:
- D2 pathway disinhibition: Loss of dopamine reduces D2-mediated inhibition of the indirect pathway
- GPe hyperactivity: Increased GPe activity (contrary to earlier models)
- STN overdrive: Excessive excitatory drive to the GPi
- Motor symptoms: Resultant increased inhibition of thalamocortical projections causes bradykinesia and rigidity
The GPe is increasingly recognized as a target for deep brain stimulation (DBS):
- GPi-DBS: Traditional target, effective for dyskinesia management
- GPe-DBS: Emerging target with potential advantages for gait and freezing of gait
- Mechanism: High-frequency stimulation overrides pathological oscillations
- Dopamine replacement: L-DOPA and dopamine agonists restore dopaminergic tone
- D2 agonists: Direct activation of D2 receptors normalizes indirect pathway activity
- Adenosine antagonists: A2A antagonists (e.g., istradefylline) may modulate GPe activity
In Huntington's disease, the pattern of GPe dysfunction differs from PD:
- Early stage: Loss of striatal medium spiny neurons leads to reduced GPe inhibition
- Hyperkinetic movements: GPe hyperactivity contributes to chorea
- Late stage: Progressive GPe degeneration leads to hypokinetic symptoms
- GPe subtypes: Identification of distinct neuronal populations with different functions
- Circuit-specific interventions: Optogenetic and chemogenetic approaches to modulate GPe activity
- Biomarkers: GPe activity patterns as biomarkers for disease progression
- Cell replacement: GPe neuron transplantation approaches
- 6-OHDA rats: Classic PD model showing GPe abnormalities
- MPTP primates: Non-human primate models of PD
- Genetic models: Mouse models with Parkin, LRRK2, and alpha-synuclein mutations
- Neuroimaging: PET and SPECT can detect GPe changes in advanced PD
- Electrophysiology: LFP recordings from implanted electrodes reveal GPe oscillations
- DBS programming: GPe responses to stimulation parameters
- Levodopa response: GPe activity correlates with medication efficacy
The study of Globus Pallidus Externus In Movement Regulation has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Beva MD, Wilson CJ. Globus pallidus externus. Journal of Neuroscience (2002)
- Bugalho P. Globus pallidus externus in movement disorders. Movement Disorders (2008)
- Alam M, et al. Globus pallidus externus deep brain stimulation for Parkinson's disease. Brain Stimulation (2019)
- Steigerwald F, et al. Neuronal activity of the globus pallidus internus in Parkinson's disease. Annals of Neurology (2019)
- Ketzef M, et al. Functional organization of the external globus pallidus. Nature Neuroscience (2017)
- Abdi A, et al. The external globus pallidus: circuits and functions. Journal of Neural Transmission (2020)
- Hernandez VM, et al. Decline of striatal tyrosine hydroxylase and the GPe in Parkinson's disease. Brain (2021)
- Mallet N, et al. Dichotomy of striatal and pallidal function in movement disorders. Current Opinion in Neurobiology (2022)